AE Wealth Management
FTXH icon

AE Wealth Management’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

AE Wealth Management’s Portfolio FTXH Stock Details FTXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-159,408
Closed -$4.21M – 1792
2022
Q2 		$4.21M Buy
+159,408
New +$4.21M 0.03% 438

Other funds holding FTXH

Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Raymond James & Associates
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Credit Suisse
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
WFA
WMG Financial Advisors Knoxville, Tennessee $265M AUM 16.66% 1-Year Est. Return
Integrated Advisors Network
Integrated Advisors Network Dallas, Texas $2.19B AUM 21.82% 1-Year Est. Return
Steward Partners Investment Advisory
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return
Kesler Norman & Wride
Kesler Norman & Wride Ogden, Utah $643M AUM 27% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AE Wealth Management's FTXH Position: Q3 2022 in Review

AE Wealth Management sold out of First Trust Nasdaq Pharmaceuticals ETF (FTXH) in Q3 2022, closing a stake of 159,408 shares — an estimated $4.21M sold.

AE Wealth Management first reported a position in FTXH in Q2 2022 and held it in 1 quarter. The position peaked at $4.21M in Q2 2022. 26 funds tracked by Wall St. Rank hold FTXH as of Q3 2022.

  • AE Wealth Management reported no remaining First Trust Nasdaq Pharmaceuticals ETF position as of Q3 2022 after selling out during the quarter.
  • AE Wealth Management sold 159,408 First Trust Nasdaq Pharmaceuticals ETF shares in Q3 2022, an estimated $4.21M.
  • AE Wealth Management first reported a position in First Trust Nasdaq Pharmaceuticals ETF in Q2 2022 and held it in 1 quarter.
  • AE Wealth Management's First Trust Nasdaq Pharmaceuticals ETF position peaked at $4.21M in Q2 2022.
  • 26 funds tracked by Wall St. Rank held First Trust Nasdaq Pharmaceuticals ETF as of Q3 2022.

Based on AE Wealth Management's 13F filing for Q3 2022, filed 25 Oct 2022.